NCT03968874

Brief Summary

The primary purpose of this project is to determine the effect of morning bright light therapy (MBLT) on sleep in Veterans with traumatic brain injury (TBI). Secondarily, the project aims to identify blood-based brain biomarkers (BBBM) associated with sleep in Veterans. Specific Aim 1. Determine the effect of MBLT on sleep quality in Veterans (primary outcome). Specific Aim 2. Determine the effect of MBLT on downstream effectors of improved sleep, including cognition, mood, and quality of life measures in Veterans (exploratory outcomes). Specific Aim 3. Determine the effect of MBLT on levels of specific BBBM related to sleep, and whether changes in specific BBBM predict response to MBLT (secondary outcome). This study can now be completed 100% remotely.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 14, 2025

Status Verified

November 1, 2025

Enrollment Period

6.3 years

First QC Date

May 23, 2019

Last Update Submit

November 12, 2025

Conditions

Keywords

Veterans

Outcome Measures

Primary Outcomes (1)

  • Change in Insomnia Severity Index (ISI)

    Measures self-reported insomnia severity; total score range = 0-28 (higher total score = worse insomnia)

    Baseline; after 4 weeks of intervention; and 2 months after the end of intervention

Secondary Outcomes (1)

  • Change in NFL, GFAP, UCH-L1, and total tau

    Baseline; after 4 weeks of intervention; and 2 months after the end of intervention

Study Arms (2)

Light box

EXPERIMENTAL

Commercially available lightbox emitting 10,000 lux of light. Subjects asked to use lightbox everyday for an hour for 4 weeks upon waking.

Device: Light box therapy

Negative Ion Generator

SHAM COMPARATOR

Commercially available negative ion generator. Subjects asked to use everyday for an hour for 4 weeks upon waking.

Device: Negative Ion Generator

Interventions

The intervention is sitting in front of a lightbox for 1 hour in the morning upon waking up.

Light box

The intervention is sitting in front of a modified negative ion generator for 1 hour in the morning upon waking up.

Negative Ion Generator

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran
  • English-speaking
  • Accessible by phone

You may not qualify if:

  • Decisional impairment
  • Macular degeneration
  • Bipolar disorder
  • Shift work
  • Currently using lightbox or negative ion generator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Portland VA Medical Center

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Miranda Lim, MD, PhD

    Portland VA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2019

First Posted

May 30, 2019

Study Start

August 1, 2019

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

November 14, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

All non-identifiable data will be made available to qualified researchers on request to the study PI.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
Information will be sent as soon as is practical and will be available as long as the PI is available.
Access Criteria
Legitimate research agenda, including but not limited to request to double-check presented or published results and novel analyses.

Locations